|
Colavito, Sierra A; Zou, Mike R; Yan, Qin et al. (2014) Significance of glioma-associated oncogene homolog 1 (GLI1) expression in claudin-low breast cancer and crosstalk with the nuclear factor kappa-light-chain-enhancer of activated B cells (NF?B) pathway. Breast Cancer Res 16:444
|
|
Breindel, Jerrica L; Haskins, Jonathan W; Cowell, Elizabeth P et al. (2013) EGF receptor activates MET through MAPK to enhance non-small cell lung carcinoma invasion and brain metastasis. Cancer Res 73:5053-65
|
|
Bai, Yalai; Cheng, Huan; Bordeaux, Jennifer et al. (2013) Comparison of HER2 and phospho-HER2 expression between biopsy and resected breast cancer specimens using a quantitative assessment method. PLoS One 8:e79901
|
|
Held, Matthew A; Langdon, Casey G; Platt, James T et al. (2013) Genotype-selective combination therapies for melanoma identified by high-throughput drug screening. Cancer Discov 3:52-67
|
|
Stern, David F (2011) ""Competence"" progress. Mol Cell 42:411-2
|
|
Tworkoski, Kathryn; Singhal, Garima; Szpakowski, Sebastian et al. (2011) Phosphoproteomic screen identifies potential therapeutic targets in melanoma. Mol Cancer Res 9:801-12
|
|
Bai, Yalai; Tolles, Juliana; Cheng, Huan et al. (2011) Quantitative assessment shows loss of antigenic epitopes as a function of pre-analytic variables. Lab Invest 91:1253-61
|
|
Singhal, G; Akhter, M Z; Stern, D F et al. (2011) DNA triplex-mediated inhibition of MET leads to cell death and tumor regression in hepatoma. Cancer Gene Ther 18:520-30
|
|
Stern, David F (2010) EGFs and ERBBs--brief history and prospects. Semin Cell Dev Biol 21:917-21
|
|
Agarwal, S; Zerillo, C; Kolmakova, J et al. (2009) Association of constitutively activated hepatocyte growth factor receptor (Met) with resistance to a dual EGFR/Her2 inhibitor in non-small-cell lung cancer cells. Br J Cancer 100:941-9
|
Showing the most recent 10 out of 54 publications
